Biosynthetic Technologies acquires Innoleo

Indianapolis-based Biosynthetic Technologies, which makes synthetic compounds called estolides from organic fatty acids found in various bio-derived oils, has acquired Innoleo, a specialist in castor oil and derivatives located in Ohio.

The products of both companies have applications in multiple industries, including personal care.

“The unique structure of castor oil offers interesting properties, making it appropriate for various industrial applications,” said Mark Miller, CEO at Biosynthetic Technologies. In particular, he noted, it is high in ricinoleic acid, making it suitable in a wide variety of applications, including personal care.

Latest Issues

in-cosmetics Korea 2026

COEX, Seoul
1 - 3 July 2026

Connex-C Asia 2026

Lee Kong Chian School of Medicine, Ong Tiong Tat and Irene Tan Liang Kheng Auditorium
23rd - 24th July 2026